Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Hypometabolism as a therapeutic target in Alzheimer's disease.

Costantini LC, Barr LJ, Vogel JL, Henderson ST.

BMC Neurosci. 2008 Dec 3;9 Suppl 2:S16. doi: 10.1186/1471-2202-9-S2-S16. Review.

PMID:
19090989
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Maalouf M, Rho JM, Mattson MP.

Brain Res Rev. 2009 Mar;59(2):293-315. doi: 10.1016/j.brainresrev.2008.09.002. Epub 2008 Sep 25. Review.

PMID:
18845187
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Neuroprotection in diet-induced ketotic rat brain after focal ischemia.

Puchowicz MA, Zechel JL, Valerio J, Emancipator DS, Xu K, Pundik S, LaManna JC, Lust WD.

J Cereb Blood Flow Metab. 2008 Dec;28(12):1907-16. doi: 10.1038/jcbfm.2008.79. Epub 2008 Jul 23.

PMID:
18648382
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Ketone bodies as a therapeutic for Alzheimer's disease.

Henderson ST.

Neurotherapeutics. 2008 Jul;5(3):470-80. doi: 10.1016/j.nurt.2008.05.004. Review.

PMID:
18625458
[PubMed - indexed for MEDLINE]
5.

Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog.

Studzinski CM, MacKay WA, Beckett TL, Henderson ST, Murphy MP, Sullivan PG, Burnham WM.

Brain Res. 2008 Aug 21;1226:209-17. doi: 10.1016/j.brainres.2008.06.005. Epub 2008 Jun 11.

PMID:
18582445
[PubMed - indexed for MEDLINE]
6.

The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial.

Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH.

Lancet Neurol. 2008 Jun;7(6):500-6. doi: 10.1016/S1474-4422(08)70092-9. Epub 2008 May 2.

PMID:
18456557
[PubMed - indexed for MEDLINE]
7.

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.

Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette CM, Schmechel D, Rogers J, Stephan DA.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4441-6. doi: 10.1073/pnas.0709259105. Epub 2008 Mar 10.

PMID:
18332434
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.

Rockwood K, Fay S, Gorman M, Carver D, Graham JE.

BMC Neurol. 2007 Aug 30;7:26.

PMID:
17760991
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cerebral metabolic adaptation and ketone metabolism after brain injury.

Prins ML.

J Cereb Blood Flow Metab. 2008 Jan;28(1):1-16. Epub 2007 Aug 8. Review.

PMID:
17684514
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Low-carbohydrate nutrition and metabolism.

Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD.

Am J Clin Nutr. 2007 Aug;86(2):276-84. Review.

PMID:
17684196
[PubMed - indexed for MEDLINE]
Free Article
11.

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.

Craft S.

Curr Alzheimer Res. 2007 Apr;4(2):147-52. Review.

PMID:
17430239
[PubMed - indexed for MEDLINE]
12.

Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease.

Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP.

Neurobiol Dis. 2007 Apr;26(1):212-20. Epub 2007 Jan 13.

PMID:
17306982
[PubMed - indexed for MEDLINE]
13.

D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo.

Mejía-Toiber J, Montiel T, Massieu L.

Neurochem Res. 2006 Dec;31(12):1399-408. Epub 2006 Nov 18.

PMID:
17115265
[PubMed - indexed for MEDLINE]
14.

Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.

Mahley RW, Huang Y.

Acta Neurol Scand Suppl. 2006;185:8-14. Review.

PMID:
16866905
[PubMed - indexed for MEDLINE]
15.

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM.

J Alzheimers Dis. 2006 Mar;9(1):13-33.

PMID:
16627931
[PubMed - indexed for MEDLINE]
16.

A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis.

Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, Humala N, Thiyagarajan M, Wang J, Pasinetti GM.

BMC Neurosci. 2006 Apr 3;7:29.

PMID:
16584562
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The ketogenic diet: from molecular mechanisms to clinical effects.

Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E; Institute of Neurology IRCCS C. Mondino Foundation.

Epilepsy Res. 2006 Feb;68(2):145-80.

PMID:
16523530
[PubMed - indexed for MEDLINE]
18.

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.

Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD; Rosiglitazone in Alzheimer's Disease Study Group.

Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. Epub 2006 Jan 31.

PMID:
16446752
[PubMed - indexed for MEDLINE]
19.
20.

A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease.

Van der Auwera I, Wera S, Van Leuven F, Henderson ST.

Nutr Metab (Lond). 2005 Oct 17;2:28.

PMID:
16229744
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk